![The Ministry of Science and Technology, the Ministry of Industry, and the Ministry of Welfare appoint Mok Hyun-sang, former head of the new drug development project, as the first director of the national new drug development project, and start the project in earnest.[사진= 과학기술정보통신부]](https://i0.wp.com/cdn.hellodd.com/news/photo/202103/91942_303471_1627.jpg?w=560&ssl=1)
The government appoints the head of the national drug development project project and initiates the project.
The Ministry of Science and ICT (Minister Choi Ki-young), Ministry of Trade, Industry and Energy (Minister Sung Yun-mo), and Ministry of Health and Welfare (Minister Kwon Deok-cheol) officially appointed Mok Hyun-sang, former head of the Ministry of New Drug Development Project, as the first head of the national new drug development project on the 4th. It was revealed on this day.
The national new drug development project is a project that supports the entire cycle of new drug development, from effective and leading substances to candidate substances discovery, non-clinical, clinical phases 1 and 2, and commercialization. A total of 2,1758 billion won (government expenditure 1,474.7 billion won, private 71.1 billion won) will be invested for 10 years from July this year to 2030. Through this, the goal is to create global new drugs with annual sales of more than 1 trillion won and to develop new domestic drugs.
In the future, the head of the project manager will seek new drug approval by global regulatory agencies such as the Ministry of Food and Drug Safety, the US FDA, and European EMA, discover candidates for the purpose of technology transfer at home and abroad, operate the project group including planning, evaluation, and management of clinical research projects, and alliance with global pharmaceutical companies. It will be in charge of external cooperation and support for commercialization.
In December 2016, the new head of the new head of the new drug development project was inaugurated as the head of the three departmental full-cycle new drug development projects, the predecessor of the national new drug development project. Cases), and 57 cases of technology transfer (15 trillion won in fixed-rate technology fee).
The official term of office of the project manager is three years until March 3, 2024. After evaluation, it is possible to serve for two years.
New Director Mok Hyun-sang said, “Based on the experience and know-how accumulated while operating the leading business group, we will do our best to launch the global market for domestic new drugs without spared an active investment in discovering substances in the early stages.”
Meanwhile, Director Mook completed his bachelor’s and master’s degree in industrial engineering at Seoul National University. In 1999, he founded Medipron_DVT, and served as the head of the new drug development project for all departments. Since last year, he has been the head of the new drug development business for COVID-19 treatment and vaccine.
Send SNS articles